- Home
- EYPT vs PUMP Comparison
EYPT vs PUMP Comparison
Compare EYPT & PUMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EYPT | PUMP |
|---|---|---|
| Founded | 1987 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Laboratory Analytical Instruments | Oilfield Services/Equipment |
| Sector | Industrials | Energy |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.3B | 1.0B |
| IPO Year | 2005 | 2017 |
Fundamental Metrics
Financial Performance| Metric | EYPT | PUMP |
|---|---|---|
| Price | $13.85 | $13.06 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 5 | 7 |
| Target Price | ★ $31.80 | $14.14 |
| AVG Volume (30 Days) | 1.5M | ★ 5.0M |
| Earning Date | 05-06-2026 | 04-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 100.76 |
| EPS | N/A | ★ N/A |
| Revenue | $7,539,000.00 | ★ $1,269,158,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $3,115.57 | $15.61 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $9.41 | $4.51 |
| 52 Week High | $19.11 | $18.50 |
Technical Indicators
Market Signals| Indicator | EYPT | PUMP |
|---|---|---|
| Relative Strength Index (RSI) | 53.12 | 38.60 |
| Support Level | $12.01 | $10.37 |
| Resistance Level | $14.52 | $13.25 |
| Average True Range (ATR) | 1.06 | 0.74 |
| MACD | 0.05 | -0.20 |
| Stochastic Oscillator | 34.08 | 33.44 |
Price Performance
Historical ComparisonAbout EYPT EyePoint Pharmaceuticals Inc.
EyePoint Inc focuses is a clinical-stage biopharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, that may reduce the frequency of follow-up care. The company's pipeline program includes i) DURAVYU: a sustained-release product candidate for retinal diseases, with the potential to provide patients with improved visual outcomes with less burden. ii) EYP-2301: early-stage program using Durasert E technology to deliver razuprotafib, a TIE-2 agonist targeting VE-PTP for vascular stability in retinal diseases like wet AMD.
About PUMP ProPetro Holding Corp.
ProPetro Holding Corp is a Texas-based oilfield services company. It provides hydraulic fracturing, wireline, and other complementary services to oil and gas companies engaged in the exploration and production of North American oil and natural gas resources. The company focused on the Permian Basin. The operating segments of the company are hydraulic fracturing which generates key revenue, wireline, cementing, and power generation service.